Skip to main content

Type 1 Diabetes News

Type 1 Diabetes is a chronic condition in which your body loses the ability to produce insulin, which is necessary for most cells to convert food into energy and regulate blood sugar levels. 

In the quest to develop an artificial pancreas , the development of faster-acting insulin is a crucial component – current rapid-acting insulins do not work nearly as...
(S)he said what!?
In February, Dexcom submitted an application to expand the label for the G4 Platinum CGM (continuous glucose monitor) to pediatric patients who are as young as two years...
Highlights from Maryland's back-to-back meetings.
(S)he said what?!?
On November 14, World Diabetes Day was commemorated at 574 blue-lit monuments around the world. The annual event is meant to be a rallying experience for the global...
How can we make better use of our test strips?
In mid-April, the popular press was full of reports on an exciting new paper published in the Journal of the American Medical Society on a stem-cell treatment for type 1...
To mark the end of this month’s 72nd American Diabetes Association (ADA) Scientific Sessions in Philadelphia (see conference pearls in this issue), diaTribe editor in...
Ever wondered if we have it better or worse than other countries? Dr. Dorothee Deiss reveals the state of diabetes care in Germany.
At the JP Morgan Healthcare Conference in January, Insulet announced that it has been working with an unnamed company to integrate a CGM sensor directly into its OmniPod...
(S)he said what?!?
On September 17, Vivus announced that its obesity medication Qsymia (formerly Qnexa) is now available on the US market – this happened at least several weeks earlier...
Dr. Sanjay Kaul speaks to diaTribe about the new SGLT-2 drug class.
Earlier this month, the American Diabetes Association (ADA) and the co-chairs of the Senate Diabetes Caucus, Senator Susan Collins (R-ME) and Jeanne Shaheen (D-NH),...
Retrofit CEO Jeff Hyman explains what makes data-driven weight loss – using Skype sessions and Wifi scales– so different.
On World Diabetes Day in San Francisco, Manny Hernandez of the Diabetes Hands Foundation (DHF) announced that the DHF had exceeded its goal to get 20,000 people to take...
(S)he said what!?
Two well-known endocrinologists debated the merits of inhaled insulin in the February edition of Diabetes Care.
In June, pharmaceutical giant Bristol-Myers Squibb (BMS) and its partner AstraZeneca (AZ) acquired the important biotech company Amylin for a cool $7 billion, which we...

Pages